Cancer Clinical Trials

ReadTheTrial indexes 4 studies for Cancer. The most common development stage is N/A (2 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

4 clinical trials found for Cancer.

Pipeline by Phase

PhaseTrialsDistribution
N/A 2
50%
Phase 1 1
25%
Phase 2 1
25%

Trial Status Breakdown

Trials for Cancer

Phase I Dose Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

NCT07424547 · RECRUITING · Phase 1

EQUIP - Evaluation of Quality of Imaging on a Next-generation Total Body Pet Scan in Comparison to Conventional PET

NCT07263815 · ACTIVE NOT RECRUITING · N/A

Troponin to Detect Major Cardiovasculaire Advserse Events on Immune: a Case Control Retrospective Study

NCT06007274 · COMPLETED · N/A

Phase 1/2 Study of 9-ING-41, a Glycogen Synthase Kinase-3 Beta (GSK-3β) Inhibitor, as a Single Agent and Combined With Chemotherapy, in Patients With Refractory Hematologic Malignancies or Solid Tumors

NCT03678883 · ACTIVE NOT RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Cancer?

There are 4 clinical trials listed for Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Cancer trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Cancer trials in?

Current Cancer trials are distributed across: N/A (2), Phase 1 (1), Phase 2 (1).

Find More Trials